First patient completes Hemopurifier treatment protocol in Aethlon study
Aethlon Medical (San Diego), a company that specializes in developing targeted therapeutic devices to address infectious diseases and cancer, said that the first patient enrolled in the company's FDA approved feasibility study has completed their full Hemopurifier treatment protocol without any device-related adverse events.
Dam it: CMS plays the part of Hoover
Interagency coordination at the Department of Health and Human Services is purported to be a routine fact of life nowadays, but there are signs that outside forces are pushing FDA into activity that could have a big effect on another important agency.
Google faces potential challenges, roadblocks in getting Glass adopted
When Jay Zuerndorfer, a student researcher at the Georgia Institute of Technology (Atlanta) received the opportunity to develop an application for Google Glass it was like a dream come true. Zuerndorfer and a research team from Georgia Tech were able to create speech-to-text software for Google Glass that helps hard-of-hearing users with everyday conversations. A hard-of-hearing person wears Glass while a second person speaks directly into a smart phone.